3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
17
Not yet recruiting
8
Unknown
5
Terminated
2
Recruiting
2
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
2
Lymphoid
2
Gastrointestinal
2
Other hematologic neoplasm
1
Myeloid
1
Head & Neck
1
Gynecologic
1
Classical hematology
1
Breast
1
Conditions
Ovarian Neoplasms
215
Uterine Cervical Neoplasms
144
Endometrial Neoplasms
111
Fallopian Tube Neoplasms
78
Breast Neoplasms
59
Carcinoma, Non-Small-Cell Lung
43
Colorectal Neoplasms
40
Stomach Neoplasms
35
Melanoma
31
Carcinoma, Renal Cell
29
Prostatic Neoplasms
28
Neoplasms
28
Carcinoma, Ovarian Epithelial
28
Pancreatic Neoplasms
26
Triple Negative Breast Neoplasms
25
Esophageal Neoplasms
25
Neoplasm Metastasis
24
Lung Neoplasms
23
Urinary Bladder Neoplasms
22
Head and Neck Neoplasms
21
Colonic Neoplasms
20
Vulvar Neoplasms
19
Squamous Cell Carcinoma of Head and Neck
19
Carcinoma, Transitional Cell
14
Carcinoma, Hepatocellular
14
Uterine Neoplasms
13
Small Cell Lung Carcinoma
13
Sarcoma
13
Rectal Neoplasms
12
Peritoneal Neoplasms
12
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Acquired Immunodeficiency Syndrome
×
Gynecologic
×
Clear all
NCT04141449
2025-12-31
Potlako+
Brigham and Women's Hospital
Phase 2
Active not recruiting
874 enrolled